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The 2011 Ethical, Legal, and Social Implications (ELSI) 
Congress,  ‘Exploring  the  ELSI  Universe’,  hosted  by  the 
Center for Genomics and Society in Chapel Hill, kicked 
off  with  an  inspiring  introduction  by  Eric  Green 
(Director,  National  Human  Genome  Research  Institute 
(NHGRI),  National  Institutes  of  Health,  USA)  who 
outlined the place of ELSI research in the NHGRI’s new 
strategic plan. The 3-day interdisciplinary meeting, which 
was attended by hundreds from many different countries, 
and  fields  as  varied  as  genomics,  bioethics,  the  social 
sciences, philosophy and law, offered an opportunity to 
reflect on the myriad of ethical, legal and social issues in 
genomics and to plan for the future of genomic medicine. 
Green challenged attendees to contemporize ELSI research 
and  stressed  the  importance  for  ELSI  researchers  to 
balance a foundational knowledge base with knowledge 
gained from acting as ‘research SWAT teams’ collecting 
empirical  evidence  to  inform  best  practices.  The  con-
ference presented the novel ways ELSI research is helping 
to guide the field of genomics in plotting the course from 
‘base  pairs  to  bedside’.  Here  we  cover  some  of  the 
conference highlights, including forward-looking propo  sals 
to repurpose research governance and oversight, signifi-
cant efforts in empirical research and creative methodo-
logical approaches.
ELSI in the 21st century
The opening plenary session of day 2 provided accounts of 
the ongoing role of ELSI researchers in the development 
and  implementation  of  research  governance  and  over-
sight. Jane Kaye (University of Oxford, UK) presented a 
pioneering  vision  of  a  future  in  which  research 
governance  and  oversight  should  be  aligned  with  how 
research is now being conducted in global networks (no 
longer  one  research  project,  by  one  researcher,  in  one 
jurisdiction).  As  part  of  this  change,  she  advocated  a 
move  towards  coordinated,  global,  non-duplicative 
efforts to advance ELSI research using the same approach 
and  scale  as  the  Human  Genome  Project  (see  http://
www.publichealth.ox.ac.uk/helex/  for  more  information 
on  the  Global  ELSI  Initiative).  Employing  information 
technology (IT) innovations was also advocated by Malia 
Fullerton  (University  of  Washington,  USA)  who  ex-
plained how these strategies can provide mechanisms to 
engage  participants  while  promoting  transparency  of 
governance and oversight.
Research governance and oversight structures, even if 
enhanced  through  novel  IT  solutions,  must  be 
supported by evidence-based policies. Mark Rothstein 
(University of Louisville, USA) pointed out how difficult 
it is to influence policy and noted that ELSI has been 
most effective in shaping legislation the closer it stays to 
its central mission of genomics. Concrete ways in which 
ELSI  research  can  contribute  to  policy  development 
were described by Pearl O’Rourke (Partners HealthCare 
Systems, Inc., USA). In order to produce research data 
to  inform  policies  and  educate  and  engage  various 
stakeholders, ELSI researchers must continually monitor 
and assess emerging issues in a broad research portfolio. 
Although the overarching theme of this meeting was to 
conceive of ways to contemporize and propel the field 
forward, Kathy Hudson (National Institutes of Health, 
USA) reviewed previous research ethics atrocities that 
now  serve  as  reminders  of  the  tremendous  improve-
ments  achieved  in  research  ethics  and  regulations. 
Hudson  underscored  the  need  for  new,  empirically 
informed policies to revolutionize the implementation 
of  existing  protections  and  regulations.  Through 
innovative research, ELSI researchers will lead policy 
makers  in  the  creation  of  modern  governance 
structures engineered to meet the ethical challenges of 
genomic medicine.
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With empirical evidence needed to develop well-informed 
policies,  conference  panels  and  themed  sessions  were 
accordingly dominated by talks presenting the rich and 
compelling  data  being  generated.  Major  ethical  issues 
under study in the field included topics such as health 
equality,  behavioral  genetics,  human  microbiome 
research and biobanking, to name a few.
In looking at health equality research, David Williams 
(Harvard  University,  USA)  presented  data  illustrating 
health inequalities faced by racial minority groups in the 
USA;  these  disparities  persisted  after  controlling  for 
confounding factors. Wylie Burke (University of Wash  ing-
ton, USA) spoke of the complexity of genomic research, 
especially with regard to the interaction of genetics and 
the environment. Burke and Williams urged scientists to 
forgo thinking of genes as the cause of disparities, yet to 
use  genomic  tools  as  another  way  to  understand  the 
biological effects of our social experience.
Two other pressing areas drawing much attention were 
data sharing and the return of genetic research results. 
To elucidate the intricacies of these complex issues, ELSI 
researchers reported on their explorations of the distinct 
voices  of  various  stakeholders  (for  example,  genomic 
researchers,  institutional  review  board  (IRB)  members, 
research participants and the general public).
With  regard  to  data  sharing,  findings  from  several 
studies  indicated  that  participants  want  to  be  active 
participants  with  some  control  over  the  use  of  their 
genetic data. Susan Trinidad (University of Washington, 
USA),  for  example,  reported  data  from  focus  groups 
where the majority of participants appreciated being re-
contacted  for  permission  prior  to  the  sharing  of  their 
genetic and health information with other researchers, as 
this was viewed as a sign of respect.
In an effort to treat participants as partners in research, 
there is growing consensus that at least some individual 
genetic  research  results  (IRRs)  and  incidental  findings 
(IFs) ought to be shared with participants. An overview 
by Susan Wolf (University of Minnesota, USA) discussed 
how IRRs and IFs arise in all phases of genomic research, 
and highlighted ethical challenges to be addressed, such 
as establishing criteria that make these results returnable. 
A  survey  of  genome-wide  association  study  (GWAS) 
investi  gators  presented  by  Rachel  Ramoni  (Harvard 
Medical School, USA) found that while most GWASs do 
not allow for the return of IRRs, nearly all GWAS investi-
gators expressed that there are cases when results should 
be  returned.  Janet  Williams  (The  University  of  Iowa, 
USA) described IRB chairs’ struggles in making determi-
na  tions  about  returning  genomic  IFs,  and  noted  their 
concerns with the interpretability of IFs, the potential for 
risk and harm, and a lack of existing guidelines. Initial 
results  from  a  survey  of  IRB  chairs  by  Laura  Beskow 
(Duke University, USA) also stressed the need to establish 
guidelines,  particularly  in  emerging  areas  such  as 
genotype-driven recruitment where eligible participants 
are identified based on genetic information learned about 
them in a previous study.
New ways to explore the ELSI universe
A  high  degree  of  innovation  will  be  required  of  ELSI 
researchers to engender trust, advance the field, and help 
facilitate ethical genomic research. Benefits of the inter-
disciplinary  nature  of  the  ELSI  research  program  are 
apparent  in  the  range  of  thought  and  methodological 
approaches currently used and proposed for future studies. 
For example, Rachel Haase (University of North Carolina 
at  Chapel  Hill,  USA)  presented  fresh  approaches  to 
qualitative methods using data analysis software to assess 
word  frequency  and  interpret  word  usage.  Inventive 
approaches  to  community  engagement  presented  by 
Wendy  Marsden  (University  of  Edinburgh,  UK)  also 
described advancements in technological methods that 
link participants in patient networks to genetic research.
One  session  featured  a  play  entitled  ‘It’s  Not  That 
Simple!  Genomic  Research  and  the  Consent  Process’, 
which  was  cleverly  scripted  by  Karen  Rothenberg 
(University of Maryland School of Law, USA) and Lynn 
Bush  (Columbia  University,  USA).  Lines  were  read  by 
attendees; notably, the Oscar-worthy performance of Jim 
Evans (University of North Carolina at Chapel Hill, USA) 
did not disappoint! The writing team’s ability to transform 
language  from  genuine  genetic  research  informed 
consent documents into a flawless portrayal of a family’s 
struggle as they face enrollment into a genetic research 
study  showcased  the  talents  present.  The  conference’s 
final sessions also reflected the imaginative minds at play, 
as three open-forum workshops on the future of the ‘E’, 
the  ‘L’  and  the  ‘S’  in  ELSI  research  provided  a  unique 
platform for attendees to express their final thoughts and 
reiterate proposed directions for the field.
The future of ELSI
The  closing  talk  by  Eric  Juengst  (University  of  North 
Carolina at Chapel Hill, USA) imparted the future of the 
‘I’ in ELSI research. Juengst described the historical and 
ongoing  changes  in  the  ELSI  research  portfolio  and 
stressed  that  the  goal  of  realizing  genomic  medicine, 
which was emphasized in Green’s introductory remarks, 
might itself pose some ELSI challenges that we should 
remain  alert  to.  He  also  proposed  international 
collabora  tion to avoid unintended social consequences 
of genomic medicine in other parts of the world. Juengst 
encouraged  ELSI  researchers  to  engage  the  more 
challenging  and  controversial  issues  in  genomics, 
rather  than  simply  trying  to  ‘smooth  the  path’  for 
genomic medicine.
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research while providing more critical assessment of the 
advances  being  made  was  a  major  theme  of  the  ELSI 
Congress and will be an important challenge facing ELSI 
researchers. A recent spate of requests for applications 
from  the  NHGRI,  which  seeks  novel  integrative 
approaches  to  incorporate  ELSI  research  into  genomic 
research  to  capture  real-time  assessments  of  genetic 
information being delivered directly to participants and 
applied  to  clinical  care,  affords  ELSI  researchers  an 
oppor  tunity  to  practice  balancing  these  roles  of  facili-
tators  and  critical  assessors.  ELSI  researchers  must  be 
ready to evaluate and anticipate ethical issues that may 
arise  in  this  new  era  of  genomic  research  to  ensure  a 
successful  path  forward;  many  at  the  ELSI  Congress 
seemed prepared to take on that challenge.
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